2020
DOI: 10.1080/14728222.2020.1846720
|View full text |Cite
|
Sign up to set email alerts
|

Is neurotrophin-3 (NT-3): a potential therapeutic target for depression and anxiety?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
19
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 27 publications
(19 citation statements)
references
References 129 publications
0
19
0
Order By: Relevance
“…Furthermore, neurotrophins, especially BDNF and NT-3, have been investigated in mood disorders and found to play a role in depression and anxiety. 28 He et al showed that serum BDNF levels were lower and negatively associated with depressive symptoms in young Chinese adults with acne vulgaris. 13 They also found that the severity of the disease was not related to depression scores in their acne patients, as did we in LSC.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, neurotrophins, especially BDNF and NT-3, have been investigated in mood disorders and found to play a role in depression and anxiety. 28 He et al showed that serum BDNF levels were lower and negatively associated with depressive symptoms in young Chinese adults with acne vulgaris. 13 They also found that the severity of the disease was not related to depression scores in their acne patients, as did we in LSC.…”
Section: Discussionmentioning
confidence: 99%
“…NT-3 is thought to play a role in the neurobiological processes associated with mood and anxiety disorders. In recent years, it has been proposed that NT-3 is a potential pharmacological target for mood disorders due to its effects on monoamine neurotransmitters, regulation of synaptic plasticity and neurogenesis, enhancement of BDNF signaling, and regulation of the HPA axis ( de Miranda et al, 2020 ). There are even fewer studies on the role of NT-4/5 in depression.…”
Section: Discussionmentioning
confidence: 99%
“…As described above, improvements in the production of monoamine and serotonin, the HPA axis, and expression of neurotrophic factors have been proposed as treatments for depression ( Jacobson and Sapolsky, 1991 ; Smith et al, 1995 ; Manji et al, 2001 ; Nestler et al, 2002 ; Okamoto et al, 2003 ; Adams et al, 2008 ; Otsuki et al, 2008 ; Sanacora et al, 2008 ; Liu et al, 2017 ; de Miranda et al, 2020 ). Our studies revealed that acupuncture stimulation ameliorates SDS-induced immobility in mice.…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies have revealed that numerous anxiolytic substances, including endogenous neurotransmitters, anxiolytic drugs, and nutraceuticals, are also neurotrophic in that they also activate the brain derived neurotrophic factor (BDNF) pathway, the neurotrophin-3 (NT-3) pathways and the nerve growth factor (NGF) pathway by binding to or potentiating the TRKA -C neurotrophin receptors and directly activating the ERK1/2 signaling pathway leading to neuroplasticity [26][27][28][29][30][31][32][33][34][35][36][37]. This is important because neurotrophins can regulate neuroplasticity not only during development but also during learning and the establishment of memories [35][36][37].…”
Section: Introductionmentioning
confidence: 99%
“…The changes in cell shape associated with the establishment of new neurites and therefore potentially new connections is known as neuroplasticity [35][36][37]. Recent attention has been brought to the idea that in so far as anxiety is related to the memories of trauma and the establishment of a learned threat level in the perception of stressors through neuroplasticity, perhaps anxiolytic phytochemicals with neurotrophic activity can be used to reduce anxiety not only through changes neurotransmitter activity, but also by providing the plasticity required to relearn and reduce the emotional value ascribed to a stressor thereby also facilitating the reduction in anxiety [26][27][28][29][30][31][32][33][34]. Therefore anxiolytic phytochemical neurotrophins are important because they offer a new area of research into not simply adjusting neurotransmitter activity, but to the development of natural treatments and drugs that can actually reverse the neurocircuitry associated with anxiety through neuroplasticity and relearning.…”
Section: Introductionmentioning
confidence: 99%